Connections GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:04 12/05/2026 pm IST			5-day change	1st Jan Change
1,891.50 ^GBX	+2.55%		+1.86%	+3.67%

08:45pm	European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading	MT
11/05	Global markets live: Alphabet, Cerebras, Compass, GSK, Rockwool…

49

Listed companies

49

Private companies

730

Insiders

Relation chart of related listed companies: GSK plc

Active Relations

Past Relations

Related listed companies: GSK plc

Christopher Viehbacher

Menelas Nicolas Pangalos

SONY GROUP CORPORATION

Wendy Becker

INTERTEK GROUP PLC

Laura Atherton

BIOMARIN PHARMACEUTICAL INC.

Elizabeth Anderson

VODAFONE GROUP PLC

Simon Dingemans

Anne-Francoise Nesmes

Anne-Francoise Nesmes

WAVE LIFE SCIENCES LTD.

Hwa Jin Song Montesano

MELIÁ HOTELS INTERNATIONAL, S.A.

María Cristina de Luna Basagoiti

GENMAB A/S

Deirdre Connelly

Paolo Augusto Paoletti

VISCOFAN, S.A.

María Cristina de Luna Basagoiti

ASPEN PHARMACARE HOLDINGS LIMITED

David Redfern

JCR PHARMACEUTICALS CO., LTD.

ALNYLAM PHARMACEUTICALS, INC.

Yvonne Greenstreet

Stuart Arbuckle

PHARMA MAR, S.A.

Martín-Delgado Fernando

GLAXOSMITHKLINE PAKISTAN LIMITED

Dmytro Oliinyk

INOVIO PHARMACEUTICALS, INC.

ULTIMATE PRODUCTS PLC

Andrew Milne

OMADA HEALTH, INC.

Anne Beal

CANDEL THERAPEUTICS, INC.

William Nichols

Paul-Peter Tak

INTELLIA THERAPEUTICS, INC.

Jesse Goodman

REVOLUTION MEDICINES, INC.

Arunthathy Nirmalini Pandite

GENENTA SCIENCE S.P.A.

Carlo Russo

John Cantello

PRAXIS PRECISION MEDICINES, INC.

Dean Mitchell

Stuart Arbuckle

ACHIEVE LIFE SCIENCES, INC.

MIRUM PHARMACEUTICALS, INC.

INSILICO MEDICINE CAYMAN TOPCO

BRII BIOSCIENCES LIMITED

Zhi Hong

Lisa Trivison Beck

IMMUNOCORE HOLDINGS PLC

PERSPECTIVE THERAPEUTICS, INC.

Maya Martinez-Davis

ELICIO THERAPEUTICS, INC.

Robert Ruffolo

Carol Ashe

Active Relations

Past Relations

Relationship chart for related private companies: GSK plc

Active Relations

Past Relations

Related private companies: GSK plc

Human Genome Sciences, Inc.

Medical Specialties

Adrian Rawcliffe

Dan Troy

David Redfern

Healthcare Businesswomens Association

Miscellaneous Commercial Services

Jim Weiss

Allene Diaz

Biotechnology Innovation Organization

Miscellaneous Commercial Services

Elicio Therapeutics, Inc. (United States)

Biotechnology

Robert Ruffolo

Carol Ashe

Duke University

Other Consumer Services

Allen W. Mangel

Gwendolyn Powell Painter

University of Oxford

Other Consumer Services

Crispin Davis

Wendy Becker

Institute of Chartered Accountants in England & Wales

Miscellaneous Commercial Services

Julie Brown

Ian Maurice Gray Prosser

The American Institute of Certified Public Accountants

Miscellaneous Commercial Services

Christopher Chipman

Paul Hawran

Cancer Research Institute

Medical/Nursing Services

Laurie Glimcher

Jim Weiss

Protez Pharmaceuticals, Inc.

Pharmaceuticals: Major

Peter A. Sears

Luigi Xerri

The Royal Society of Chemistry

Miscellaneous Commercial Services

Richard Sykes

Brian D. Morgan

Kyowa Kirin International Plc

Pharmaceuticals: Major

Paul Carter

Thomas Stratford

GlaxoSmithKline, Inc.

Pharmaceuticals: Major

Christopher Gent

Andrew Witty

University of the Sciences in Philadelphia

Other Consumer Services

Kent E. Lieginger

Catherine Sohn

Council on Foreign Relations, Inc.

Investment Trusts/Mutual Funds

George Poste

James Murdoch

Norgine Pharmaceuticals Ltd.

Pharmaceuticals: Major

Richard Taylor

Jo Pillai

ProPharma Partners Ltd.

Miscellaneous Commercial Services

Peter J. Cozens

Jill Rasmussen

The Institute of International Finance, Inc.

Miscellaneous Commercial Services

Tom de Swaan

Urs Rohner

Lifearc

Miscellaneous Commercial Services

Ian Gilham

Michael Anthony Romanos

New York State Bar Association

Miscellaneous Commercial Services

James R. Beery

Urs Rohner

National Academy of Sciences

Miscellaneous Commercial Services

American Academy of Arts & Sciences

Miscellaneous Commercial Services

Judy Lewent

Laurie Glimcher

Lucy Shapiro

National Academy of Medicine (United States)

Miscellaneous Commercial Services

The Royal College of Physicians

Other Consumer Services

James Shannon

David Clark

Pennsylvania Institute of Certified Public Accountants

Miscellaneous Commercial Services

Christopher Chipman

Paul Hawran

Hatteras Venture Partners

Investment Managers

Charlie Sanders

John Lepore

The Business Council

Miscellaneous Commercial Services

John A. Young

Larry Culp

Scarab Genomics LLC

Biotechnology

Martin Rosenberg

Richard Lesniewski

Springboard Enterprises, Inc.

Internet Software/Services

Lauren Flanagan

Amy Millman

Foundation for the National Institutes of Health, Inc.

Miscellaneous Commercial Services

Joseph Feczko

Jim Weiss

Confederation of British Industry

Miscellaneous Commercial Services

Ian Maurice Gray Prosser

Vindi Banga

The Bioindustry Association

Miscellaneous Commercial Services

Peter J. Cozens

Chris Molloy

Michael Anthony Romanos

Harvard Medical School

Other Consumer Services

Laurie Glimcher

Yvonne Greenstreet

European Financial Services Round Table

Miscellaneous Commercial Services

Tom de Swaan

Urs Rohner

British Pharmacological Society

Investment Trusts/Mutual Funds

Dimitri Dimitriou

Heather Giles

Menelas Nicolas Pangalos

ViiV Healthcare Ltd.

Pharmaceuticals: Major

John Apeler Keller

David Redfern

Autifony Therapeutics Ltd.

Pharmaceuticals: Major

Elaine Jones

Charles H. Large

Giuseppe S. Alvaro

Belle Capital Management LLC

Investment Managers

Irene Hrusovsky

Lauren Flanagan

Amy Millman

Stanford University School of Medicine

Other Consumer Services

Lucy Shapiro

Christopher Viehbacher

Saïd Business School

Other Consumer Services

Dame Cox

Vindi Banga

Wendy Becker

Genomics England Ltd.

Miscellaneous Commercial Services

Jonathan Symonds

Eliot Forster

Office for Strategic Co-ordination of Health Research

Eliot Forster

Patrick J. T. Vallance

GlaxoSmithKline Consumer Healthcare Holdings Ltd.

Financial Conglomerates

Simon Dingemans

David Redfern

Brian McNamara

GlaxoSmithKline Intellectual Property Holdings Ltd.

Financial Conglomerates

Simon Dingemans

Paul Blackburn

Sapience Therapeutics, Inc.

Biotechnology

Robert Ruffolo

Howard H. Pien

Cardior Pharmaceuticals GmbH

Pharmaceuticals: Major

Russell Greig

Ulrich Granzer

Gammadelta Therapeutics Ltd.

Biotechnology

Peter Goodfellow

Michael Owen

Avacta Life Sciences Ltd.

Pharmaceuticals: Major

Eliot Forster

Michael Owen

Avaana Capital Advisors LLP

Investment Managers

Anjali Bansal

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	28
Miscellaneous Commercial Services	21
Biotechnology	18
Other Consumer Services	7
Investment Managers	3
Financial Conglomerates	2
Investment Trusts/Mutual Funds	2
Medical Specialties	2
Internet Software/Services	2
Pharmaceuticals: Other	2

Countries of related companies

United States	43
United Kingdom	28
Japan	3
France	3
Germany	3
Spain	3
Denmark	3
Canada	2
Australia	2
South Africa	1

GSK plc is a United Kingdom-based biopharma company. The Companyâ€™s segments include Commercial Operations and Research and Development. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) with antibiotics. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development. The Company also engaged in ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody. The Company also owns HS235, a potential molecule for the treatment of pulmonary hypertension (PH).

Employees

66,841

Sector

Pharmaceuticals

Calendar

14/05 - Ex-dividend date - 0.17 GBX

More about the company